Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.

Uno Y, Kanda M, Sato Y, Shimizu D, Umeda S, Hattori N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Motoyama S, Koike M, Kodera Y.

Anticancer Res. 2019 Nov;39(11):6015-6023. doi: 10.21873/anticanres.13807.

PMID:
31704827
2.

Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.

Oya H, Kanda M, Takami H, Hibino S, Shimizu D, Niwa Y, Koike M, Nomoto S, Yamada S, Nishikawa Y, Asai M, Fujii T, Nakayama G, Sugimoto H, Fujiwara M, Kodera Y.

Dis Esophagus. 2015 Feb-Mar;28(2):188-95. doi: 10.1111/dote.12156. Epub 2013 Oct 21.

PMID:
24147998
3.

PRAME Expression as a Potential Biomarker for Hematogenous Recurrence of Esophageal Squamous Cell Carcinoma.

Baba H, Kanda M, Sawaki K, Shimizu D, Umeda S, Koike M, Kodera Y, Fujii T.

Anticancer Res. 2019 Nov;39(11):5943-5951. doi: 10.21873/anticanres.13799.

PMID:
31704819
4.

Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.

Oya H, Kanda M, Koike M, Iwata N, Niwa Y, Shimizu D, Takami H, Sueoka S, Hashimoto R, Ezaka K, Nomoto S, Yamada S, Fujii T, Nakayama G, Sugimoto H, Fujiwara M, Kodera Y.

Dis Esophagus. 2016 Aug;29(6):663-9. doi: 10.1111/dote.12373. Epub 2015 May 8.

PMID:
25951896
5.

Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray.

Sang M, Gu L, Liu F, Lian Y, Yin D, Fan X, Ding C, Huang W, Liu S, Shan B.

Arch Med Res. 2016 Apr;47(3):151-61. doi: 10.1016/j.arcmed.2016.06.001. Epub 2016 Jun 27.

PMID:
27362547
6.

Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.

Chen X, Wang L, Yue D, Liu J, Huang L, Yang L, Cao L, Qin G, Li A, Wang D, Wang M, Qi Y, Zhang B, van der Bruggen P, Zhang Y.

Histol Histopathol. 2017 Aug;32(8):793-803. doi: 10.14670/HH-11-847. Epub 2016 Nov 21.

PMID:
27868181
7.

Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.

Shi X, Chen X, Fang B, Ping Y, Qin G, Yue D, Li F, Yang S, Zhang Y.

Biomed Pharmacother. 2019 Apr;112:108632. doi: 10.1016/j.biopha.2019.108632. Epub 2019 Feb 20.

8.

Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.

Liu Q, Cui X, Yu X, Bian BS, Qian F, Hu XG, Ji CD, Yang L, Ren Y, Cui W, Zhang X, Zhang P, Wang JM, Cui YH, Bian XW.

Mol Cancer. 2017 Apr 21;16(1):81. doi: 10.1186/s12943-017-0650-7.

9.

EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.

Matsuda T, Takeuchi H, Matsuda S, Hiraiwa K, Miyasho T, Okamoto M, Kawasako K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Omori T, Kitagawa Y.

Ann Surg Oncol. 2014 Jun;21 Suppl 3:S356-64. doi: 10.1245/s10434-014-3579-8. Epub 2014 Feb 25.

PMID:
24566863
10.

RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.

Wang L, Hou Z, Hasim A, Abuduerheman A, Zhang H, Niyaz M, Awut I, Upur H, Sheyhidin I.

Int J Oncol. 2018 Mar;52(3):861-871. doi: 10.3892/ijo.2018.4253. Epub 2018 Jan 24.

PMID:
29393393
11.

TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.

Ozawa D, Yokobori T, Sohda M, Sakai M, Hara K, Honjo H, Kato H, Miyazaki T, Kuwano H.

Ann Surg Oncol. 2016 Jan;23(1):282-9. doi: 10.1245/s10434-014-4259-4. Epub 2014 Dec 2.

PMID:
25448803
12.

Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Nakahara Y, Yamasaki M, Sawada G, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mimori K, Mori M, Doki Y.

Oncology. 2016;90(6):347-55. doi: 10.1159/000445323. Epub 2016 Apr 16.

PMID:
27082627
13.

Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.

Yokobori T, Bao P, Fukuchi M, Altan B, Ozawa D, Rokudai S, Bai T, Kumakura Y, Honjo H, Hara K, Sakai M, Sohda M, Miyazaki T, Ide M, Nishiyama M, Oyama T, Kuwano H.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1566-73. doi: 10.1245/s10434-015-4831-6. Epub 2015 Aug 27.

PMID:
26310281
14.

Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.

Cheng X, Wei L, Huang X, Zheng J, Shao M, Feng T, Li J, Han Y, Tan W, Tan W, Lin D, Wu C.

Gastroenterology. 2017 Jun;152(8):1985-1997.e12. doi: 10.1053/j.gastro.2017.02.006. Epub 2017 Feb 14.

PMID:
28209530
15.

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.

Cui XB, Zhang SM, Xu YX, Dang HW, Liu CX, Wang LH, Yang L, Hu JM, Liang WH, Jiang JF, Li N, Li Y, Chen YZ, Li F.

J Transl Med. 2016 May 17;14(1):137. doi: 10.1186/s12967-016-0884-y.

16.

SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.

Cui XB, Shen YY, Jin TT, Li S, Li TT, Zhang SM, Peng H, Liu CX, Li SG, Yang L, Li N, Hu JM, Jiang JF, Li M, Liang WH, Li Y, Wei YT, Sun ZZ, Wu CY, Chen YZ, Li F.

J Transl Med. 2015 Oct 6;13:321. doi: 10.1186/s12967-015-0681-z.

17.

Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.

Toyozumi T, Hoshino I, Takahashi M, Usui A, Akutsu Y, Hanari N, Murakami K, Kano M, Akanuma N, Suitoh H, Matsumoto Y, Sekino N, Komatsu A, Matsubara H.

Ann Surg Oncol. 2017 Oct;24(11):3446-3455. doi: 10.1245/s10434-016-5666-5. Epub 2016 Nov 23.

PMID:
27882471
18.

Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.

Qin G, Lian J, Yue D, Chen X, Nan S, Qi Y, Li B, Cui G, Li X, Zhao S, Zhang Y.

Oncol Rep. 2017 Sep;38(3):1724-1732. doi: 10.3892/or.2017.5809. Epub 2017 Jul 12.

19.

Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.

Ito S, Kawano Y, Katakura H, Takenaka K, Adachi M, Sasaki M, Shimizu K, Ikenaka K, Wada H, Tanaka F.

Lung Cancer. 2006 Jan;51(1):79-88. Epub 2005 Oct 12.

PMID:
16225959
20.

High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.

Zhai X, Xu L, Zhang S, Zhu H, Mao G, Huang J.

Oncotarget. 2016 Jan 26;7(4):4871-81. doi: 10.18632/oncotarget.6741.

Supplemental Content

Support Center